Found: 8
Select item for more details and to access through your institution.
Rethinking intercurrent events in defining estimands for tuberculosis trials.
- Published in:
- Clinical Trials, 2022, v. 19, n. 5, p. 522, doi. 10.1177/17407745221103853
- By:
- Publication type:
- Article
Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Practical approaches to Bayesian sample size determination in non‐inferiority trials with binary outcomes.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 8, p. 1127, doi. 10.1002/sim.9661
- By:
- Publication type:
- Article
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Disseminating the research findings from the adolescents and adults living with Perinatal HIV (AALPHI) study: an approach from young people living with HIV.
- Published in:
- Research Involvement & Engagement, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40900-024-00541-x
- By:
- Publication type:
- Article
Formalising the induction of patient and public involvement contributors on trial oversight committees.
- Published in:
- Research Involvement & Engagement, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40900-021-00269-y
- By:
- Publication type:
- Article
Toxicity associated with tuberculosis chemotherapy in the REMoxTB study.
- Published in:
- 2018
- By:
- Publication type:
- journal article